CClinicalTrials.gg
RecruitingNCT03695887Updated May 14, 2026

A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes

An Early Phase 1 interventional study of Nitrous Oxide Inhalant Product and Placebo in Burns and Pain, Acute, sponsored by University of Manitoba. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by University of Manitoba · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes. The traditional use of narcotics is challenging as the therapeutic window between analgesia and suppression of breathing becomes narrow with the intense pain and high doses of narcotics needed for dressing changes.

Read the detailed description

The normal challenges of using narcotics are increased in burn patients, who have significantly altered metabolism. Unfortunately, the use of regular general anesthesia or conscious sedation is not a viable option due to the resources required, and as the hypermetabolism of burn injury would result in compromised wound healing with repeated periods of without eating related halting of nutritional intake. This has led to the use of a number of adjuncts ranging from nonmedical (virtual reality, mindfulness, hypnosis etc.) to medication (ketamine, anxiolytics etc.). Historically Nitrous oxide has been used in similar settings where severe procedural pain is of relatively shorter duration, such as tooth extraction, labor or minor surgical procedures. Nitrous oxide is a rapidly acting analgesic that takes effect seconds after inhalation, and lasts minutes. While a randomized trial of Nitrous oxide in burn care has been proposed, the only published information currently available is in a Chinese medical journal.

To address this a gap in knowledge, a pilot Randomized Controlled trial is proposed to evaluate if Nitrous Oxide in the form of limited dose inhaler canisters can be used to improve pain control during burn dressing changes compared to placebo canisters.

02

Conditions studied

  • Burns
  • Pain, Acute

Keywords

  • burns, pain, dressing change, nitrous oxide
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • adult burn patients admitted to the Health Sciences Centre
  • total body surface area burned of 5-20%

Exclusion criteria

Exclusion criteria

  • admitted to intensive care unit
  • unable to participate in the measurement outcomes (sedated, cognitively impaired, unable to understand English or visually impaired)
  • medical condition that precludes using nitrous oxide (respiratory disease and significant cardiovascular disease 5).
  • pregnant
  • physically unable to hold the canister
  • \<90% SaO2 on room air
  • face burn
  • pre-injury narcotics (relative exclusion)
  • use of IV ketamine
  • pre-existing lung injury
04

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Nitrous Oxide Inhalant Product

    Nitrous oxide

    Drug: Nitrous Oxide Inhalant Product

  • Placebo comparator
    Placebo

    placebo comparator

    Drug: Placebo

Interventions

  • DrugNitrous Oxide Inhalant Product

    Nitrous Oxide Inhalant Product

  • DrugPlacebo

    Inactive comparator

05

What researchers measure

Primary outcomes

  1. Burn Specific Pain Anxiety Scale

    The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of: 1. Worry about wound-healing 2. Fear of procedural pain 3. Fear of losing control because of pain 4. Fear of pain during dressing change 5. Pain severity 6. Keyed up because of enduring pain 7. Concern about wound healing 8. Preoccupied with pain 9. Tension during dressing change Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.

    Time frame: 1 hour before dressing change

  2. Burn Specific Pain Anxiety Scale

    The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of: 1. Worry about wound-healing 2. Fear of procedural pain 3. Fear of losing control because of pain 4. Fear of pain during dressing change 5. Pain severity 6. Keyed up because of enduring pain 7. Concern about wound healing 8. Preoccupied with pain 9. Tension during dressing change Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.

    Time frame: during dressing change

  3. Burn Specific Pain Anxiety Scale

    The experience of the dressing change for the patient will also be assessed using the Burn specific pain and anxiety scale which consists of: 1. Worry about wound-healing 2. Fear of procedural pain 3. Fear of losing control because of pain 4. Fear of pain during dressing change 5. Pain severity 6. Keyed up because of enduring pain 7. Concern about wound healing 8. Preoccupied with pain 9. Tension during dressing change Responses for each item are on a visual analogue scale ranging from "least" to "most". The response is normalized to a value between 0 and 1, representing the location selected on the line, divided by the total length of the line. The responses will be used to examine a possible relationship procedural and non procedural pain between the nurse and the patient.

    Time frame: 1 hour after dressing change

  4. Visual Analogue Scale for pain

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain").

    Time frame: 1 hour before dressing change

  5. Visual Analogue Scale for pain

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain").

    Time frame: during dressing change

  6. Visual Analogue Scale for pain

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("No pain") and 100 ("worst possible pain").

    Time frame: 1 hour after dressing change

  7. Visual Analogue Scale for anxiety

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety").

    Time frame: 1 hour before dressing change

  8. Visual Analogue Scale for anxiety

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety").

    Time frame: during dressing change

  9. Visual Analogue Scale for anxiety

    The items are scored on a 100 mm visual analog line with two reference points given values of 0 ("no anxiety") and 100 ("worst possible anxiety").

    Time frame: 1 hour after dressing change

Secondary outcomes

  1. Anxiolytic given

    The amount of anxiolytic given one hour prior to the dressing change.

    Time frame: 1 hour before dressing change

  2. Anxiolytic given

    The amount of anxiolytic given during the dressing change.

    Time frame: during dressing change

  3. Anxiolytic given

    The amount of anxiolytic given one hour after the dressing change.

    Time frame: 1 hour after dressing change

Other outcomes

  1. Systolic blood pressure

    After administration of inhaled nitrous oxide, systolic blood pressure will be measured.

    Time frame: 5 minute mark during burn dressing change

  2. Systolic blood pressure

    After administration of inhaled nitrous oxide, systolic blood pressure will be measured.

    Time frame: 10 minute mark during burn dressing change

  3. Systolic blood pressure

    After administration of inhaled nitrous oxide, systolic blood pressure will be measured.

    Time frame: 15 minute mark during burn dressing change

  4. Systolic blood pressure

    After administration of inhaled nitrous oxide, systolic blood pressure will be measured.

    Time frame: 20 minute mark during burn dressing change

  5. Diastolic blood pressure

    After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured.

    Time frame: 5 minute mark during burn dressing change

  6. Diastolic blood pressure

    After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured.

    Time frame: 10 minute mark during burn dressing change

  7. Diastolic blood pressure

    After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured.

    Time frame: 15 minute mark during burn dressing change

  8. Diastolic blood pressure

    After administration of inhaled nitrous oxide, Diastolic blood pressure will be measured.

    Time frame: 20 minute mark during burn dressing change

  9. Mean arterial pressure

    After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured.

    Time frame: 5 minute mark during burn dressing change

  10. Mean arterial pressure

    After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured.

    Time frame: 10 minute mark during burn dressing change

  11. Mean arterial pressure

    After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured.

    Time frame: 15 minute mark during burn dressing change

  12. Mean arterial pressure

    After administration of inhaled nitrous oxide, mean arterial pressure (mmHg) will be measured.

    Time frame: 20 minute mark during burn dressing change

  13. Heart rate

    After administration of inhaled nitrous oxide, heart rate will be measured.

    Time frame: 5 minute mark during burn dressing change

  14. Heart rate

    After administration of inhaled nitrous oxide, heart rate will be measured.

    Time frame: 10 minute mark during burn dressing change

  15. Heart rate

    After administration of inhaled nitrous oxide, heart rate will be measured.

    Time frame: 15 minute mark during burn dressing change

  16. Heart rate

    After administration of inhaled nitrous oxide, heart rate will be measured.

    Time frame: 20 minute mark during burn dressing change

  17. Oxygen saturation

    After administration of inhaled nitrous oxide, oxygen saturation will be measured.

    Time frame: 5 minute mark during burn dressing change

  18. Oxygen saturation

    After administration of inhaled nitrous oxide, oxygen saturation will be measured.

    Time frame: 10 minute mark during burn dressing change

  19. Oxygen saturation

    After administration of inhaled nitrous oxide, oxygen saturation will be measured.

    Time frame: 15 minute mark during burn dressing change

  20. Oxygen saturation

    After administration of inhaled nitrous oxide, oxygen saturation will be measured.

    Time frame: 20 minute mark during burn dressing change

06

Study locations

1 of 1 sites recruiting
  • University of Manitoba
    Winnipeg, Manitoba R3A 1R9, Canada
    • Justin P Gawaziuk, MSc · Contact · jgawaziuk@hsc.mb.ca · 2047873669
    • Sarvesh Logsetty, MD · Principal investigator
    Recruiting
07

References and documents

Publications

  • Gregoretti C, Decaroli D, Piacevoli Q, Mistretta A, Barzaghi N, Luxardo N, Tosetti I, Tedeschi L, Burbi L, Navalesi P, Azzeri F. Analgo-sedation of patients with burns outside the operating room. Drugs. 2008;68(17):2427-43. doi: 10.2165/0003495-200868170-00003. PubMed 19016572 ↗
  • Yuxiang L, Lu T, Jianqiang Y, Xiuying D, Wanfang Z, Wannian Z, Xiaoyan H, Shichu X, Wen N, Xiuqiang M, Yinsheng W, Ming Y, Guoxia M, Guangyi W, Wenjun H, Zhaofan X, Hongtai T, Jijun Z. Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial. Trials. 2012 May 24;13:67. doi: 10.1186/1745-6215-13-67. PubMed 22624697 ↗
  • Li YX, Tang HT, Zhou WF, Hu XY, Xiao SC, Niu XH, Li YC, Wu YS, Yao M, Wang HX, Xia ZF, Zhao JJ. [Analgesic and sedative effects of inhaling a mixture of nitrous oxide and oxygen on burn patient during and after dressing change]. Zhonghua Shao Shang Za Zhi. 2013 Dec;29(6):537-40. Chinese. PubMed 24495641 ↗
  • Taal LA, Faber AW, van Loey NE, Reynders CL, Hofland HW. The abbreviated burn specific pain anxiety scale: a multicenter study. Burns. 1999 Sep;25(6):493-7. doi: 10.1016/s0305-4179(99)00034-0. PubMed 10498356 ↗
  • Becker DE, Rosenberg M. Nitrous oxide and the inhalation anesthetics. Anesth Prog. 2008 Winter;55(4):124-30; quiz 131-2. doi: 10.2344/0003-3006-55.4.124. PubMed 19108597 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03695887
Lead sponsor
University of Manitoba
Responsible party
Dr. Sarvesh Logsetty (Professor, University of Manitoba) — Principal investigator
First posted
Oct 4, 2018
Start date
Oct 1, 2019
Primary completion
Dec 1, 2028 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
May 14, 2026

Study contacts

Sarvesh Logsetty, MD
Contact
logsetty@umanitoba.ca
2047878682
Sarvesh Logsetty
principal investigator · University of Manitoba

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion